Stroke Clinical Research Study

Acorda Milestone Stroke Study <- click for more information

Study Purpose: To determine the effect of two dose strengths of study medication taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.

Basic Eligibility Criteria:

  • Male and female patients between ages 18 and over
  • Must be 6 months post-ischemic stroke

Bipi Re-spect Study <- click for more information

Study Purpose: To demonstrate that the efficacy of dabigatran 110mg or 150mg BID is superior to ASA 100mg AD in prevention of stroke of undetermined source.

Basic Eligibility Criteria:

  • 60 yrs old or 50-59 with additonal risk factors
  • Modified Rankin Scale of >4 at time of randomization or inability to swallow medications.
  • Major risk cardioembolic source of embolism (more information can be found at the study title link).

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Irina Gamerman, M.D., Clinical Research Manager, at [email protected]

Clinical Research Coordinator:

Micah Sy at [email protected]

You may also call 203.333.1151 and we will be happy to answer any of your questions.